ALPAT Plant Advanced Technologies SA

4.365USD3.980 EUR · EPA0.00%Mkt Cap: 4.97M USDP/E: 6.63

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable so…

Key Statistics

Company
Market Cap4.97M USD
Enterprise Value—
Revenue (TTM)1.49M USD
Gross Profit1.37M USD
Net Income (TTM)624.52K USD
Revenue/Share1.35 USD
Last Price4.365 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees11
CountryFR
SectorHealthcare
IndustryBiotechnology
ISINFR0010785790
Valuation
P/E (Trailing)6.63
P/E (Forward)-199.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S3.35
P/B0.45
EPS (TTM)0.66 USD
EPS (Forward)-0.02 USD
52W Range
3.51014% of range9.718
52W High9.718 USD
52W Low3.510 USD
Profitability
Gross Margin109.45%
Oper. Margin-21.08%
EBITDA Margin21.49%
Profit Margin50.04%
ROE5.79%
ROA3.48%
ROIC-1.51%
ROCE-1.79%
Growth
Revenue Growth-6.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.74M USD
CapEx (TTM)452.34K USD
FCF Margin—
FCF Yield—
Net Debt—
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.38
Current Ratio1.06
Quick Ratio0.45
Book Value/Sh9.60 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.1.14M
Float632.43K
Insiders48.10%
Institutions0.00%
Technical
SMA 504.468 (-2.3%)
SMA 2006.348 (-31.2%)
Beta0.83
S&P 52W Chg12.00%
Avg Vol (30d)296
Avg Vol (10d)466
Technical Indicators
RSI (14)49.9
MACD-0.0194
MACD Signal-0.0453
MACD Hist.+0.0259
BB Upper4.637 USD
BB Middle4.280 USD
BB Lower3.922 USD
BB Width16.69%
ATR (14)0.0730 USD
Vol Ratio (20d)0.03x

About Plant Advanced Technologies (EPA: ALPAT)

›

Plant Advanced Technologies (EPA: ALPAT) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 11 employees.

The shares were at 3.980 EUR on 19 November 2026, down 52.6% over 52 weeks. Its 52-week range is 3.200 EUR to 8.860 EUR: the price is 55.1% below the high and 24.4% above the low.

At a market capitalisation of 4.53M EUR, it trades at 6.6 times trailing earnings. The median trailing P/E of its 13 largest Biotechnology peers is 33.5, a discount of 80% for ALPAT.

Plant Advanced Technologies reports return on equity of 5.8%, an operating margin of -21.1% and revenue down 6.4% year over year.

Its Piotroski F-score is 4 out of 9, an average reading of its financial health.